Papa Medical Inc. is an end-to-end cannabis dosing solution provider in the United States that sells nebulizer. The Company is engaged in the key activities in the cannabis and consuming e-vapors industry, from the research and development, formulation design, e-liquid production, e-liquid filling to e-liquid co-packing services. It has approximately 50 series of e-vapors. Its products include iPrefer 8-D, iPrefer 20, iPrefer 30, iPrefer 36-A, AIR INS U1 and AIR INS L1. It provides comprehensive solutions to companies in the cannabis and tobacco industries. The Company's cannabis e-vapors are sold directly by it, with most of its sales being to other cannabis dosing brands who purchase the product from it on an original design manufacturer basis and sells the products under their brand name, although its Cannapresso brand name and/or sub-brand names of VLPUL and HOOLOO may be included on the product. Its cannabis E-vapors primarily use various technologies, such as AiMesh and feelmixX.
BörsenkürzelPAPA
Name des UnternehmensPapa Medical Inc
IPO-datum- -
CEOHua (Jian)
Anzahl der mitarbeiter29
WertpapierartOrdinary Share
Geschäftsjahresende- -
Addresse202 North California Ave
StadtCITY OF INDUSTRY
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl91744
Telefon16268550800
Websitehttps://www.cannapresso.com
BörsenkürzelPAPA
IPO-datum- -
CEOHua (Jian)
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten